Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare. Sep 25, 2024, 01:42pm EDT Team of Medical Research ...

The House of Representatives just passed a resolution condemning the “horrors of socialism” by a 285 to 98 margin. All the no votes were cast by Democrats indicating that a majority of the members ...

Complex problems are rarely solved by a simple stroke of a pen. President Donald Trump's proposal to enact a most-favored-nation policy for drug pricing in the United States will do more harm than ...

History has a short memory. In recent weeks, as Vice President Kamala Harris’s policy proposals sparked a national conversation about price-controls, that phenomenon is on full display. Price-controls ...

For decades, America’s drug-price debate has centered on a fundamental tension: How do policymakers encourage expensive research and development, while ensuring that companies keep final prices ...

Lawmakers in both parties are increasingly embracing the idea of price controls on medicines — and in doing so, they’re making a losing bet. Price controls involve a fundamental tradeoff: lower prices ...

Novo Nordisk just announced price cuts for Ozempic and Wegovy, whose list prices as recently as last year were around $1,000 a month. Patients buying directly from the manufacturer will be able to pay ...

“We support efforts to lower the price of medicines and improve patient access, but these efforts must be grounded in market-based principles that respect free enterprise and foster future medical ...

Karl Marx famously said that history repeats itself first as tragedy, then as farce. Vice President Kamala Harris is bringing that aphorism to life by putting price controls at the center of her ...

As an alum of Trump 1.0 at Health and Human Services and a strong supporter of President Trump’s drive to deliver on his MAHA healthcare agenda including lowering drug prices for American patients, I ...

A new proposal suggests freezing prices on staple foods — but economists warn price controls could bring shortages and other unintended consequences. Ahead of the 2026 midterms, affordability remains ...

Brian Albrecht is chief economist at the International Center for Law & Economics and co-writes the newsletter Economic Forces. On the 2023 campaign trail, Vice President Kamala Harris’s first major ...